Ancora Advisors’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-6,000
Closed -$63.3K 1858
2024
Q4
$63.3K Sell
6,000
-29,000
-83% -$306K ﹤0.01% 937
2024
Q3
$508K Buy
+35,000
New +$508K 0.01% 505